The U.S. Securities and Exchange Commission has decided to drop a lawsuit accusing two Dubai men of insider trading in Onyx Pharmaceuticals Inc while the cancer drugmaker was mulling a takeover bid by Amgen Inc. Without explanation, the SEC asked U.S. District Judge Paul Oetken in Manhattan to dismiss its…
SEC drops Onyx insider trading lawsuit against Dubai men
September 16, 2015